Extended-release arbaclofen for muscle stiffness in multiple sclerosis
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study tests a new extended-release tablet called arbaclofen to see if it helps reduce muscle stiffness and spasms in people with multiple sclerosis (MS). If you join, you'll take the study drug or a placebo (a tablet with no active medicine) and report how your symptoms feel.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have a confirmed multiple sclerosis (MS) diagnosis (relapsing-remitting or secondary progressive).
- You must have had muscle stiffness or spasms from MS for at least 6 months.
- You must be able to clearly describe your muscle stiffness and separate it from other MS symptoms.
- You must use effective birth control if you or your partner can become pregnant.
- You cannot have untreated severe depression or anxiety, a recent cancer (except treated skin cancer), or other significant health issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether wearing a special suit at home can help manage muscle stiffness (spasticity) or lack of coordination (ataxia) caused by multiple sclerosis. The suit delivers gentle stimulation to improve movement in your arms or legs.
This study looks at patterns of muscle stiffness (spasticity) in people with multiple sclerosis and how these patterns affect daily life and well-being. It aims to better understand the link between spasticity and quality of life.
This trial tests whether IPN10200, a Botox-like treatment, is safe and helps reduce stiff, tight upper-arm muscles caused by spasticity after stroke or brain injury. You may be able to join if you meet specific timing, prior-treatment, and muscle-stiffness measurements.
This study tests an investigational drug (BMS-986368) to see if it helps reduce muscle stiffness and spasms caused by multiple sclerosis. It may be an option if you have had spasticity for at least 6 months and are not currently using other treatments that cannot be paused.
This Phase 2 trial tests whether cannabis can reduce muscle stiffness (spasticity) in people with multiple sclerosis. You may be able to participate if your stiffness is not improving with your current treatments.
This study tests an experimental pill (BMS-986368) that targets two brain chemicals to reduce muscle stiffness after a stroke. It's for people who had a stroke in the last 4 to 18 months and have moderate tightness in their elbow and wrist.
Hear when a new Spasticity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.